Clinical Trials Browser

Phase 3 × Carcinoma, Non-Small-Cell Lung × toripalimab × Clear all

NCT06437977 2025-03-13

neoR-TORCH

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT04772287 2021-02-26

Adjuvant Toripalimab Plus Chemotherapy for EGFR/ALK Mutation Negative Stage II-IIIB(N2) NSCLC (LungMate-008)

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung